Lotus Ventures Inc. (CSE:J) (Frankfurt: LV9) (the “Company” or “Lotus”), an Okanagan based cannabis cultivator with a recently licensed state-of-the-art facility, launched its new consumer brand – Lotus Cannabis Co. (“Lotus Cannabis” or the “Brand”). Lotus Cannabis is the only cannabis brand owned and operated by Lotus Ventures Inc. and the Company intends to continue to be listed on the Canadian Securities Exchange under the ticker symbol “J”.

In addition to the Brand, Lotus’ new website is now up and running at (lotuscannabis.ca). The new branding, packaging and website reflect the team’s commitment to quality. The new Lotus website makes our focus apparent, and our packaging design represents the targeting of discerning cannabis connoisseurs. The Company anticipates growing a proprietary product, unique to the Canadian market, and will issue a separate press release for its official strain launch.

Closing of Financing

Lotus has closed a non-brokered private placement financing by issuance of an additional 9,485,000 units at a price of $0.20 per unit. The gross proceeds were $1,897,000 and the proceeds will be used for facility expansion and general corporate purposes. Each unit consists of one common share and one transferrable share purchase warrant, each warrant exercisable to purchase one common share at $0.26 per share for five years. Securities issued are subject to a four-month hold period under applicable Canadian securities laws and no finders’ fees were paid.

Lotus Ventures Inc.
“Dale McClanaghan”
Dale McClanaghan, President and CEO

About Lotus Ventures Inc.
Lotus Ventures Inc. (CSE:J) is a licensed cannabis producer under the Cannabis Act and Cannabis Regulations, holding a Standard Cultivation and Sale for Medical Purposes license. The Company’s unique business model combines an upstream financing model with Auxly Cannabis Group Inc. and a downstream licensing model with farmer/grower partners utilizing Lotus technology and intellectual property. The initial 22,500 square foot facility in Spallumcheen, B.C. is a purpose built, state of the art indoor facility with proprietary cultivation processes.

For Further Information:
Dale McClanaghan, CEO: [email protected] (604) 644-9844
Daniel McRobert, Investor Relations: [email protected] (604) 842-4625

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Click here to connect with Lotus Ventures Inc (CSE:J) for an Investor Presentation.

Source: lotuscannabis.ca

 Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.

For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.

Keep reading... Show less

The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .

Keep reading... Show less

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less